-
Amount Of Epogen And Procrit Given To Patient Tripled Since Early ’90s
Higher Levels Of Popular Anemia Drugs May Increase Risk Of Heart Problems And Death The most recent discussion about safety issues surrounding the anemia drug epoetin — sold by Amgen as Epogen, sold by…
-
Is The End Near For Sanofi-Aventis Antibiotic Ketek?
December 2006 FDA Meeting Will Focus On Side Effect Risks, While Fraud Investigation Continues A November 14, 2006 Associated Press (AP) article was the first to report that in December 2006 the FDA will…
-
Merck Settlement For Vioxx Cases Said To Be Several Years Away
UPDATE: Global Settlement Offer Made By Merck To End Vioxx Litigation According To November 9, 2007 News Reports Merck Agrees to Settle Vioxx Suits for $4.85 Billion (NY Times) Merck Is Expected to Announce…
-
Ortho Evra: More Women Sue J&J Over Birth Control Patch
Lawsuits Allege Serious Blood Clots Conditions Such As Pulmonary Embolism, With One Young Woman Dying From Using Ortho Evra In early November 2006 two new California Ortho Evra lawsuits were filed in San Francisco…
-
Natrecor: Safety Concerns And Off-Label Investigation Plague Scios And J&J
Medical Journal Articles About Natrecor And Renal Failure May Have Been Cause Of Reduced Natrecor Use In Late 2005 Steve Johnson provides some insights about the so-called "off-label" use of prescription drugs with his…